"17 Secrets To Protecting Your Children From Sexual Predators!"
Subscribe to Health Articles (RSS)
Subscribe to Health Articles (Email)
Jump start your diet with a FREE BOTTLE of White Tea with Acai!
This is a limited time offer and will expire soon!
Studies have shown that white tea has a concentration of antioxidants that is three times higher than in green tea. White tea leaves are harvested at a younger age which in turn hold the purist nutrients. White tea is not fermented at all, while green tea is partly fermented. Because of that, and the careful handling, white tea retains more content of beneficial antioxidants.
Click Here for your Free Trial* - You pay only for S&H, the Bottle is FREE and yours to keep! White Tea With Acai Free Trial - Click Here
P.S. This offer is for US only!
P.P.S. Check out how can you earn $1,000 just for trying out the free sample of
White Tea With Acai - Click Here
I currently have articles in the Bladder sub-categories listed below:
Current Bladder News
- Urodynamix Technologies Ltd. Receives FDA 510(k) Clearance for UroNIRS 2000(T...
- VANCOUVER, BRITISH COLUMBIA-- - Urodynamix Technologies Ltd. today announced that it has obtained 510 clearance from the U.S. Food and Drug Administration to market the UroNIRS 2000 Bladder Monitor System - a second generation non-invasive medical device that uses near infrared spectroscopy to aid in the diagnosis of lower urinary tract symptoms in a urology office setting.
- Endo Shifts Gears With Indevus (Forbes)
- The first biopharma acquisition of the year as the industry consolidates.
- What's the best age to start using a bed-wetting alarm? (CNN)
- What is the best age to begin using a bed-wetting alarm?
- Endo to Spend Up to $637 Million to Purchase Indevus (Update2) (Bloomberg)
- Jan. 5 (Bloomberg) -- Endo Pharmaceuticals Holdings Inc. , the maker of Lidoderm pain patches, said it will buy Indevus Pharmaceuticals Inc. for as much as $637 million, to add new products and expand its sales force by 100 people.
- Specialty Medicines Led Rebound in U.S. Drug Approvals in 2008 (Bloomberg)
- Jan. 5 (Bloomberg) -- Medicines for rare disorders and diagnosing diseases contributed to a jump in U.S. drug approvals last year from a quarter-century low in 2007.
